BSC coordinates QUSTom, the first project that will use supercomputing to detect tumors more effectively and safely.
Read moreCientíficos de la U713 CIBERER que lidera José M. Cuezva en el Centro de Biología Molecular Sevecho Ochoa (CBMSO-UAM/CSIC) y del Hospital Universitario Puerta de Hierro de Majadahonda han demostrad...
Read moreCatalonia is participating in over 1,200 clinical trials currently underway to test new therapies and drugs in patients. This puts the BioRegion 6th in Europe in number of trial participations and 8th...
Read moreLos virus oncolíticos son virus modificados genéticamente para reconocer y atacar a las células tumorales. Se trata de un tipo de inmunoterapia innovadora con gran recorrido en el tratamiento contr...
Read moreResearchers from the CiQUS of the USC have just published an article that opens up a new immunotherapeutic path against cancer. The international study, led by the Centre's PI Eddy Sotelo and Andre...
Read moreEl European Research Council (ERC) ha concedido a la profesora Cristina Canal una de las ayudas ‘Proof of Concept’, destinadas a acercar al mercado los avances en investigación de frontera. Con e...
Read moreThe group of Childhood Cancer and Blood Disorders of the Vall d'Hebron Research Institute (VHIR) and the Pediatric Oncology and Hematology Department of the Vall d'Hebron University Hospital have part...
Read moreGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and the Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer research organizations, today announced...
Read moreAs an approach to personalised medicine, the study proposes that “mutational footprints” of DNA repair are a promising predictive genetic marker for determining which tumours will respond to certa...
Read moreThis grant will be used to develop a targeted treatment based on nanoparticles for pediatric cancer Ewing’s Sarcoma.
Read moreThanks to a new Proof of Concept Grant granted today by the European Research Council (ERC), CRG researchers led by Dr. Luis Serrano will explore new methods that improve the therapeutic effectiveness...
Read moreUn estudio dirigido por el Instituto Wellcome Sanger indica que la línea germinal humana está bien protegida de la aparición de mutaciones y que los eventos de hipermutación son poco frecuentes y ...
Read more